HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. announced today the appointment of Christopher Mengler, R.Ph., as President of Global Pharmaceuticals, the Company’s generic pharmaceutical division. In this role, Mr. Mengler will be responsible for expanding the Company’s generic business by growing capability in the U.S. market while driving global opportunities.
